Ferrer-Batallé, M.; Llop, E.; Ramírez, M.; Aleixandre, R.N.; Saez, M.; Comet, J.; De Llorens, R.; Peracaula, R.
Comparative Study of Blood-Based Biomarkers, α2,3-Sialic Acid PSA and PHI, for High-Risk Prostate Cancer Detection. Int. J. Mol. Sci. 2017, 18, 845.
https://doi.org/10.3390/ijms18040845
AMA Style
Ferrer-Batallé M, Llop E, Ramírez M, Aleixandre RN, Saez M, Comet J, De Llorens R, Peracaula R.
Comparative Study of Blood-Based Biomarkers, α2,3-Sialic Acid PSA and PHI, for High-Risk Prostate Cancer Detection. International Journal of Molecular Sciences. 2017; 18(4):845.
https://doi.org/10.3390/ijms18040845
Chicago/Turabian Style
Ferrer-Batallé, Montserrat, Esther Llop, Manel Ramírez, Rosa Núria Aleixandre, Marc Saez, Josep Comet, Rafael De Llorens, and Rosa Peracaula.
2017. "Comparative Study of Blood-Based Biomarkers, α2,3-Sialic Acid PSA and PHI, for High-Risk Prostate Cancer Detection" International Journal of Molecular Sciences 18, no. 4: 845.
https://doi.org/10.3390/ijms18040845
APA Style
Ferrer-Batallé, M., Llop, E., Ramírez, M., Aleixandre, R. N., Saez, M., Comet, J., De Llorens, R., & Peracaula, R.
(2017). Comparative Study of Blood-Based Biomarkers, α2,3-Sialic Acid PSA and PHI, for High-Risk Prostate Cancer Detection. International Journal of Molecular Sciences, 18(4), 845.
https://doi.org/10.3390/ijms18040845